Authors:
Garvey, MA
Ziemann, U
Becker, DA
Barker, CA
Bartko, JJ
Citation: Ma. Garvey et al., New graphical method to measure silent periods evoked by transcranial magnetic stimulation, CLIN NEU, 112(8), 2001, pp. 1451-1460
Authors:
de Messias, ELM
Cordeiro, NF
Sampaio, JJC
Bartko, JJ
Kirkpatrick, B
Citation: Elm. De Messias et al., Schizophrenia and season of birth in a tropical region: relationship to rainfall, SCHIZOPHR R, 48(2-3), 2001, pp. 227-234
Authors:
Knable, MB
Torrey, EF
Webster, MJ
Bartko, JJ
Citation: Mb. Knable et al., Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium, BRAIN RES B, 55(5), 2001, pp. 651-659
Authors:
van de Laar, N
Henter, L
Bartko, JJ
Wyatt, RJ
Citation: N. Van De Laar et al., Adverse events during a placebo phase for inpatients with chronic schizophrenia, BIOL PSYCHI, 50(7), 2001, pp. 487-492
Citation: Do. Perkins et al., Penny-wise and pound-foolish: The impact of measurement error on sample size requirements in clinical trials, BIOL PSYCHI, 47(8), 2000, pp. 762-766
Authors:
Arango, C
Bartko, JJ
Gold, JM
Buchanan, RW
Citation: C. Arango et al., Prediction of neuropsychological performance by neurological signs in schizophrenia, AM J PSYCHI, 156(9), 1999, pp. 1349-1357
Citation: Rr. Conley et al., Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine, AM J PSYCHI, 156(6), 1999, pp. 863-868
Authors:
Hobart, MP
Goldberg, R
Bartko, JJ
Gold, JM
Citation: Mp. Hobart et al., Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: Convergent/discriminant validity and diagnostic group comparisons, AM J PSYCHI, 156(12), 1999, pp. 1951-1957